<?xml version="1.0" encoding="UTF-8"?>
<p>Sixty‐four patients (phase 1, 
 <italic>n </italic>=
 <italic> </italic>14; phase 2, 
 <italic>n </italic>=
 <italic> </italic>50) were enrolled between 31 October 2011 and 12 December 2013. Patient demographics and baseline disease characteristics are summarized in Table 
 <xref rid="bjh15394-tbl-0001" ref-type="table">1</xref>: median age was 63·5 years (range 34–82), with 9% of patients aged ≥75 years; 52% had International Staging System (ISS) disease stage II or III; 81% had normal renal function or mild renal impairment (calculated creatinine clearance &gt;60 ml/min); and 9% had high‐risk cytogenetic abnormalities.
</p>
